The liver is an organ able to regenerate after some damage, since its cells can proliferate and recover the lost or damaged tissue. A study published in the journal Redox Biology states that the depletion of the NADPH oxidase 4 (NOX4) protein stimulate the proliferation of liver cells and liver regeneration. This discovery puts the NOX4 protein at the center of attention as a potential therapeutic target, since its inhibition could help boost liver regeneration in patients with chronic diseases.

The team that carried the study out is led by the lecturer Isabel Fabregat, from the Faculty of Medicine and Health Sciences of the UB, and member of the Bellvitge Biomedical Research Institute (IDIBELL) and the Liver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD). In the framework of the study, researchers Macarena Herranz-Itúrbide and Judit López Luque observed that mice that did not express NOX4 –in general, or specifically in the liver– recovered the liver tissue and showed a higher survival after a liver resection. The study counted on the relevant collaboration of the group led by Natalia Török, from Stanford University in California (United States).

Previous studies had suggested NOX4 inhibition to be a therapeutical tool for chronic diseases that cause fibrosis in the liver. As Isabel Fabregat notes, in this study, we have confirmed that its therapeutic application could also benefit liver regeneration, without negative effects on its correct termination."

Further information

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream